News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
88 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32181)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (232)
2 (101)
3 (1)
4 (13)
5 (26)
6 (344)
7 (346)
8 (264)
9 (107)
10 (31)
11 (18)
12 (255)
13 (267)
14 (212)
15 (206)
16 (111)
17 (4)
18 (5)
19 (157)
20 (226)
21 (187)
22 (190)
23 (79)
24 (1)
25 (3)
26 (175)
27 (201)
28 (178)
29 (232)
30 (88)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Genetown
Results of the Insulin-Only Bionic Pancreas Pivotal Trial, Which Were Presented at ADA’s 82nd Scientific Sessions, Are Published This Week in the New England Journal of Medicine
Beta Bionics, Inc. — The results of the multi-center randomized Insulin-Only Bionic Pancreas Pivotal Trial, which were presented in June at the 82nd Scientific Sessions of the American Diabetes Association, are published this week in the New England Journal of Medicine.
September 30, 2022
·
7 min read
Business
Gaston Picchio, PhD, Chief Development Officer, to Depart Arbutus at Year End
Arbutus Biopharma Corporation today announced that Gaston Picchio, PhD, Chief Development Officer, will be leaving the Company for personal reasons.
September 30, 2022
·
5 min read
Trinity Biotech Announces Results of AGM
Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Annual General Meeting (AGM).
September 30, 2022
·
2 min read
Pharm Country
Applied DNA’s Biotherapeutics Subsidiary Publishes Manuscript Demonstrating that a LinearDNA™ Vaccine Candidate was Protective in Virus Challenge Trial in Ferrets
Applied DNA Sciences, Inc. today announced the publication of a manuscript, co-authored with international academic and industry scientists, containing data demonstrating that a LinearDNA™-based vaccine candidate (the “vaccine candidate”) reduced infectious virus shedding and was protective against SARS-CoV-2 in a challenge trial in ferrets.
September 30, 2022
·
7 min read
Genetown
CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts
CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today announced it has raised a $32 million Series A funding round led by AXA IM Alts through its Global Health Private Equity.
September 30, 2022
·
5 min read
Drug Development
Biolog-id completed phase one of deploying its value-chain optimization solution in a multi-state integrated delivery network in the southeast USA
Biolog-id has completed phase one of implementing its value-chain optimization solution in a large medical center and level II trauma center in North Carolina.
September 30, 2022
·
1 min read
Pharm Country
Todos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics Platform
Todos Medical, Ltd. today announced that it has received two Notices of Allowance from the United States Patent & Trademark Office (USPTO) for patent applications covering the Company’s Total Biochemical Infrared Analysis (TBIA) Fourier Transformed Infrared (FTIR) pan-cancer blood diagnostics platform.
September 30, 2022
·
6 min read
Business
Seelos Therapeutics to Collaborate with the Healey & AMG Center for ALS in an Expanded Access Program
Seelos Therapeutics, Inc. today announced it will collaborate with the Sean M. Healey & AMG Center for ALS in an Expanded Access Program (EAP) that will be fully funded by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the ACT for ALS.
September 30, 2022
·
7 min read
Biotech Bay
NeoSpectra by Si-Ware Launches the NeoSpectra LabStore, an Online Marketplace Offering the Largest Collection of NIR Calibration Models
NeoSpectra by Si-Ware today announced the release of the first-of-its-kind marketplace of near-infrared (NIR) calibration models with the launch of the NeoSpectra LabStore.
September 30, 2022
·
5 min read
Business
Nomination committee has been appointed for Mentice AB (publ) Annual General Meeting 2023
Mentice AB a leading supplier of high-technology solutions for simulation in the medical sector with focus on endovascular procedures, announces that the nomination committee for the company’s Annual General Meeting 2023 has been appointed.
September 30, 2022
·
2 min read
Previous
4 of 9
Next